Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial.
about
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Heart dose exposure as prognos ...... nalysis of a randomized trial.
@en
Heart dose exposure as prognos ...... nalysis of a randomized trial.
@nl
type
label
Heart dose exposure as prognos ...... nalysis of a randomized trial.
@en
Heart dose exposure as prognos ...... nalysis of a randomized trial.
@nl
prefLabel
Heart dose exposure as prognos ...... nalysis of a randomized trial.
@en
Heart dose exposure as prognos ...... nalysis of a randomized trial.
@nl
P2093
P2860
P356
P1433
P1476
Heart dose exposure as prognos ...... analysis of a randomized trial
@en
P2093
F Heinzelmann
G Stamatis
H Schmidberger
K Darwiche
M Stuschke
P2860
P304
P356
10.1093/ANNONC/MDX069
P50
P577
2017-05-01T00:00:00Z